| 1 | ApoA-I Protects Pancreatic β-Cells From Cholesterol-Induced Mitochondrial Damage and Restores Their Ability to Secrete Insulin | 5.4 | 4 | Citations (PDF) |
| 2 | ApoA-I Protects Pancreatic β-Cells From Cholesterol-Induced Mitochondrial Damage and Restores Their Ability to Secrete Insulin | 5.4 | 4 | Citations (PDF) |
| 3 | Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction | 5.8 | 9 | Citations (PDF) |
| 4 | Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction | 4.3 | 28 | Citations (PDF) |
| 5 | Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis | 5.4 | 24 | Citations (PDF) |
| 6 | ApoA-I and Diabetes | 5.4 | 22 | Citations (PDF) |
| 7 | Use of High-Refractive Index Hydrogels and Tissue Clearing for Large Biological Sample Imaging | 4.9 | 4 | Citations (PDF) |
| 8 | Annexin A6 and NPC1 regulate LDL-inducible cell migration and distribution of focal adhesions | 3.7 | 16 | Citations (PDF) |
| 9 | Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover | 4.8 | 38 | Citations (PDF) |
| 10 | HDL maturation and remodelling | 2.4 | 17 | Citations (PDF) |
| 11 | Phosphatidylserine enhances anti‐inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways | 0.7 | 20 | Citations (PDF) |
| 12 | HDL and Diabetes | 8.0 | 6 | Citations (PDF) |
| 13 | HDL and Endothelial Function | 8.0 | 11 | Citations (PDF) |
| 14 | Moderate‐ and High‐Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men | 4.3 | 30 | Citations (PDF) |
| 15 | Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model | 3.0 | 15 | Citations (PDF) |
| 16 | Statin Prescription Patterns and Associations with Subclinical Inflammation | 2.2 | 4 | Citations (PDF) |
| 17 | Fibroblast growth factor 21 in heart failure | 3.6 | 31 | Citations (PDF) |
| 18 | Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans | 9.1 | 29 | Citations (PDF) |
| 19 | Lipoprotein (a) and the risk of elevated depressive symptoms: The Multi-Ethnic Study of Atherosclerosis | 3.1 | 7 | Citations (PDF) |
| 20 | Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention | 4.3 | 110 | Citations (PDF) |
| 21 | High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity | 3.6 | 16 | Citations (PDF) |
| 22 | The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank | 0.9 | 33 | Citations (PDF) |
| 23 | APOA1: a Protein with Multiple Therapeutic Functions | 4.9 | 145 | Citations (PDF) |
| 24 | Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors | 5.5 | 41 | Citations (PDF) |
| 25 | High Density Lipoproteins and Diabetes | 4.8 | 44 | Citations (PDF) |
| 26 | HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis | 2.9 | 36 | Citations (PDF) |
| 27 | HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research | 10.1 | 266 | Citations (PDF) |
| 28 | The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study | 2.8 | 6 | Citations (PDF) |
| 29 | microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke | 4.9 | 16 | Citations (PDF) |
| 30 | Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease | 1.6 | 19 | Citations (PDF) |
| 31 | Role of High‐Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control | 4.3 | 50 | Citations (PDF) |
| 32 | Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study | 3.3 | 6 | Citations (PDF) |
| 33 | Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! | 16.0 | 111 | Citations (PDF) |
| 34 | Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice | 8.5 | 8 | Citations (PDF) |
| 35 | Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease | 5.4 | 12 | Citations (PDF) |
| 36 | Opening ASBMB publications freely to all | 2.3 | 1 | Citations (PDF) |
| 37 | Opening ASBMB publications freely to all | 4.8 | 1 | Citations (PDF) |
| 38 | Protein Backbone and Average Particle Dynamics in Reconstituted Discoidal and Spherical HDL Probed by Hydrogen Deuterium Exchange and Elastic Incoherent Neutron Scattering | 4.4 | 2 | Citations (PDF) |
| 39 | Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages | 3.6 | 12 | Citations (PDF) |
| 40 | The data must be accessible to all | 2.3 | 3 | Citations (PDF) |
| 41 | Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease | 0.9 | 23 | Citations (PDF) |
| 42 | The Data Must Be Accessible to All | 4.8 | 2 | Citations (PDF) |
| 43 | The data must be accessible to all | 3.6 | 1 | Citations (PDF) |
| 44 | Opening ASBMB publications freely to all | 3.6 | 1 | Citations (PDF) |
| 45 | Relationship of fibroblast growth factor 21 with kidney function and albuminuria: multi-ethnic study of atherosclerosis | 0.8 | 14 | Citations (PDF) |
| 46 | The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis | 2.0 | 28 | Citations (PDF) |
| 47 | Fibroblast growth factor 21 in non-alcoholic fatty liver disease | 5.5 | 118 | Citations (PDF) |
| 48 | The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis | 3.7 | 7 | Citations (PDF) |
| 49 | Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis | 0.9 | 19 | Citations (PDF) |
| 50 | High-density lipoproteins induce miR-223–3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer | 0.9 | 30 | Citations (PDF) |
| 51 | Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats | 5.4 | 33 | Citations (PDF) |
| 52 | Translocator protein localises to CD11b+ macrophages in atherosclerosis | 0.9 | 27 | Citations (PDF) |
| 53 | Multimodal Imaging Analyses of Brain Hippocampal Formation Reveal Reduced Cu and Lipid Content and Increased Lactate Content in Non-Insulin-Dependent Diabetic Mice | 3.9 | 11 | Citations (PDF) |
| 54 | For the Sake of Science | 4.8 | 1 | Citations (PDF) |
| 55 | For the sake of science | 3.6 | 1 | Citations (PDF) |
| 56 | Apolipoprotein A‐l improves pancreatic β‐cell function independent of the ATP‐binding cassette transporters ABCA1 and ABCG1 | 0.7 | 20 | Citations (PDF) |
| 57 | Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus | 7.5 | 23 | Citations (PDF) |
| 58 | A Letter from the Editors-in-Chief | 3.6 | 1 | Citations (PDF) |
| 59 | Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle | 3.7 | 58 | Citations (PDF) |
| 60 | For the sake of science | 2.3 | 1 | Citations (PDF) |
| 61 | The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits | 3.7 | 2 | Citations (PDF) |
| 62 | Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis | 0.9 | 21 | Citations (PDF) |
| 63 | High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study) | 5.5 | 32 | Citations (PDF) |
| 64 | Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini‐review | 2.5 | 21 | Citations (PDF) |
| 65 | Fibroblast growth factor 21 in chronic kidney disease | 1.2 | 31 | Citations (PDF) |
| 66 | Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells | 5.6 | 70 | Citations (PDF) |
| 67 | Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL | 6.3 | 33 | Citations (PDF) |
| 68 | Cholesteryl ester transfer protein and its inhibitors | 3.6 | 81 | Citations (PDF) |
| 69 | Relationship of Lipids and Lipid-Lowering Medications With Cognitive Function | 3.6 | 15 | Citations (PDF) |
| 70 | Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk | 1.7 | 11 | Citations (PDF) |
| 71 | Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin | 4.3 | 6 | Citations (PDF) |
| 72 | The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis | 0.9 | 11 | Citations (PDF) |
| 73 | Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease | 1.9 | 19 | Citations (PDF) |
| 74 | The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages | 2.4 | 25 | Citations (PDF) |
| 75 | Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk | 2.0 | 56 | Citations (PDF) |
| 76 | AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages | 2.6 | 25 | Citations (PDF) |
| 77 | Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate | 3.6 | 28 | Citations (PDF) |
| 78 | Development of 3D printing filaments for bespoke X-Ray phantoms 2018, , 1-3 | | 3 | Citations (PDF) |
| 79 | Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia | 3.0 | 21 | Citations (PDF) |
| 80 | CETP inhibition, statins and diabetes | 0.9 | 16 | Citations (PDF) |
| 81 | Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome | 0.9 | 172 | Citations (PDF) |
| 82 | The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments | 3.7 | 24 | Citations (PDF) |
| 83 | HDL cholesterol concentration or HDL function: which matters? | 2.2 | 45 | Citations (PDF) |
| 84 | Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study | 1.1 | 14 | Citations (PDF) |
| 85 | The role of fibroblast growth factor 21 in atherosclerosis | 0.9 | 60 | Citations (PDF) |
| 86 | Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition | 5.4 | 21 | Citations (PDF) |
| 87 | Determining Glucose Metabolism Kinetics Using <sup>18</sup>F-FDG Micro-PET/CT | 0.3 | 11 | Citations (PDF) |
| 88 | Assessing the mechanisms of cholesteryl ester transfer protein inhibitors | 2.4 | 20 | Citations (PDF) |
| 89 | A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state | 9.0 | 67 | Citations (PDF) |
| 90 | High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling | 20.0 | 121 | Citations (PDF) |
| 91 | N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats | 3.0 | 16 | Citations (PDF) |
| 92 | Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice | 2.5 | 29 | Citations (PDF) |
| 93 | HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology | 37.0 | 127 | Citations (PDF) |
| 94 | Apolipoprotein A-I interactions with insulin secretion and production | 4.0 | 46 | Citations (PDF) |
| 95 | Lipidology, cardiovascular risk, and schizophrenia | 4.0 | 5 | Citations (PDF) |
| 96 | Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial | 5.5 | 42 | Citations (PDF) |
| 97 | Scavenger receptor class B1 — a target to reduce CHD risk? | 37.0 | 1 | Citations (PDF) |
| 98 | Low-Density Lipoprotein Receptor–Dependent and Low-Density Lipoprotein Receptor–Independent Mechanisms of Cyclosporin A–Induced Dyslipidemia | 5.4 | 27 | Citations (PDF) |
| 99 | Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism | 0.5 | 31 | Citations (PDF) |
| 100 | Cholesterol efflux capacity: An introduction for clinicians | 2.9 | 56 | Citations (PDF) |
| 101 | Human macrophage cathepsin β‐mediated C‐terminal cleavage of apolipoprotein α‐I at Ser<sup>228</sup>severely impairs antiatherogenic capacity | 0.7 | 22 | Citations (PDF) |
| 102 | Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation | 2.6 | 17 | Citations (PDF) |
| 103 | In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes | 7.5 | 35 | Citations (PDF) |
| 104 | Plaque stabilizing effects of apolipoprotein A-IV | 0.9 | 31 | Citations (PDF) |
| 105 | Inhibition of inflammatory signaling pathways in 3T3‐L1 adipocytes by apolipoprotein A‐I | 0.7 | 19 | Citations (PDF) |
| 106 | New Era of Lipid-Lowering Drugs | 16.5 | 51 | Citations (PDF) |
| 107 | Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead—Pro | 5.4 | 32 | Citations (PDF) |
| 108 | High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males | 2.5 | 44 | Citations (PDF) |
| 109 | Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo | 2.5 | 22 | Citations (PDF) |
| 110 | Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis | 0.9 | 20 | Citations (PDF) |
| 111 | HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export | 11.3 | 280 | Citations (PDF) |
| 112 | The impact of LDLR function on fibroblast growth factor 21 levels | 0.9 | 2 | Citations (PDF) |
| 113 | Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? | 10.1 | 26 | Citations (PDF) |
| 114 | Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis | 1.9 | 16 | Citations (PDF) |
| 115 | Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis | 0.9 | 23 | Citations (PDF) |
| 116 | Cholesteryl Ester Transfer Protein Inhibition Enhances Endothelial Repair and Improves Endothelial Function in the Rabbit | 5.4 | 17 | Citations (PDF) |
| 117 | HDL function as a predictor of coronary heart disease events: time to re-assess the HDL hypothesis? | 13.2 | 5 | Citations (PDF) |
| 118 | Reduction in PCSK9 levels induced by anacetrapib: an off-target effect? | 3.6 | 4 | Citations (PDF) |
| 119 | Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study | 7.5 | 29 | Citations (PDF) |
| 120 | Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis | 5.4 | 13 | Citations (PDF) |
| 121 | Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence? | 2.7 | 28 | Citations (PDF) |
| 122 | Speed kills in more ways than one: Methamphetamine and atherosclerosis | 0.9 | 2 | Citations (PDF) |
| 123 | The Relationship between Total Bilirubin Levels and Total Mortality in Older Adults: The United States National Health and Nutrition Examination Survey (NHANES) 1999-2004 | 2.5 | 37 | Citations (PDF) |
| 124 | High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation | 3.6 | 38 | Citations (PDF) |
| 125 | Normalization of Low-Density Lipoprotein Receptor Expression in Receptor Defective Homozygous Familial Hypercholesterolemia by Inhibition of PCSK9 With Alirocumab | 1.2 | 30 | Citations (PDF) |
| 126 | Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects | 1.2 | 58 | Citations (PDF) |
| 127 | Cardiovascular Risk, Lipids and Pregnancy: Preeclampsia and the Risk of Later Life Cardiovascular Disease | 0.3 | 90 | Citations (PDF) |
| 128 | Cardioprotective functions of HDLs | 3.6 | 259 | Citations (PDF) |
| 129 | Inhibition of Arthritis in the Lewis Rat by Apolipoprotein A-I and Reconstituted High-Density Lipoproteins | 5.4 | 37 | Citations (PDF) |
| 130 | Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic β-Cells via a G-Protein-cAMP-PKA-FoxO1–Dependent Mechanism | 5.4 | 64 | Citations (PDF) |
| 131 | The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: The Multi-Ethnic Study of Atherosclerosis | 0.9 | 48 | Citations (PDF) |
| 132 | MicroRNA-223 coordinates cholesterol homeostasis | 7.5 | 249 | Citations (PDF) |
| 133 | Regulation of High-Density Lipoprotein Metabolism | 11.3 | 109 | Citations (PDF) |
| 134 | HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells | 14.2 | 390 | Citations (PDF) |
| 135 | Effect of Change in Body Weight on Incident Diabetes Mellitus in Patients With Stable Coronary Artery Disease Treated With Atorvastatin (from the Treating to New Targets Study) | 1.6 | 26 | Citations (PDF) |
| 136 | The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study | 7.5 | 89 | Citations (PDF) |
| 137 | Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008 | 1.7 | 64 | Citations (PDF) |
| 138 | High‐density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells | 0.7 | 52 | Citations (PDF) |
| 139 | High density lipoprotein structure, function, and metabolism: a new Thematic Series | 3.6 | 19 | Citations (PDF) |
| 140 | High-Density Lipoproteins Inhibit Vascular Endothelial Inflammation by Increasing 3β-Hydroxysteroid-Δ24 Reductase Expression and Inducing Heme Oxygenase-1 | 11.3 | 85 | Citations (PDF) |
| 141 | Trends in C-Reactive Protein Levels in US Adults From 1999 to 2010 | 3.6 | 38 | Citations (PDF) |
| 142 | Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice | 2.5 | 53 | Citations (PDF) |
| 143 | Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 Cells | 2.5 | 37 | Citations (PDF) |
| 144 | Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease | 1.4 | 17 | Citations (PDF) |
| 145 | Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages | 2.5 | 35 | Citations (PDF) |
| 146 | Relationship between atorvastatin dose and the harm caused by torcetrapib | 3.6 | 9 | Citations (PDF) |
| 147 | Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk | 3.6 | 135 | Citations (PDF) |
| 148 | Niacin Inhibits Vascular Inflammation via the Induction of Heme Oxygenase-1 | 10.1 | 80 | Citations (PDF) |
| 149 | Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes | 4.5 | 80 | Citations (PDF) |
| 150 | The inhibition of cholesteryl ester transfer protein: a long and winding road | 3.6 | 2 | Citations (PDF) |
| 151 | ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance | 0.9 | 22 | Citations (PDF) |
| 152 | Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein | 12.5 | 135 | Citations (PDF) |
| 153 | Phenotypic and Functional Changes in Blood Monocytes Following Adherence to Endothelium | 2.5 | 16 | Citations (PDF) |
| 154 | The emerging role of HDL in glucose metabolism | 25.2 | 263 | Citations (PDF) |
| 155 | Possibility of increasing cholesterol efflux by adiponectin and its receptors through the ATP binding cassette transporter A1 in HEK293T cells | 2.1 | 14 | Citations (PDF) |
| 156 | Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now? | 11.6 | 24 | Citations (PDF) |
| 157 | Isoform-specific proteolysis of apolipoprotein-E in the brain | 3.3 | 50 | Citations (PDF) |
| 158 | The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins | 0.9 | 72 | Citations (PDF) |
| 159 | Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999–2008 | 0.9 | 28 | Citations (PDF) |
| 160 | Response to statin use and serum bilirubin levels | 0.9 | 0 | Citations (PDF) |
| 161 | The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering | 2.3 | 54 | Citations (PDF) |
| 162 | Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages | 5.4 | 38 | Citations (PDF) |
| 163 | Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A
<sub>1c</sub>
in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial | 10.1 | 186 | Citations (PDF) |
| 164 | Ras/Mitogen-activated Protein Kinase (MAPK) Signaling Modulates Protein Stability and Cell Surface Expression of Scavenger Receptor SR-BI | 2.3 | 19 | Citations (PDF) |
| 165 | Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I | 5.6 | 32 | Citations (PDF) |
| 166 | Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy | 3.6 | 110 | Citations (PDF) |
| 167 | Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A‐I | 4.1 | 104 | Citations (PDF) |
| 168 | Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids | 5.4 | 121 | Citations (PDF) |
| 169 | Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I | 5.4 | 136 | Citations (PDF) |
| 170 | The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro | 5.4 | 111 | Citations (PDF) |
| 171 | High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo | 5.4 | 126 | Citations (PDF) |
| 172 | Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion | 5.4 | 273 | Citations (PDF) |
| 173 | Cholesteryl Ester Transfer Protein Penetrates Lipoproteins For Cholesteryl Ester Transfer | 0.4 | 2 | Citations (PDF) |
| 174 | Anti-inflammatory effects of apolipoprotein A-I in the rabbit | 0.9 | 82 | Citations (PDF) |
| 175 | A Method to Study the Time-Dependent Remodeling of High Density Lipoproteins by Individual-Particle Electron Cryo-Tomography | 0.4 | 4 | Citations (PDF) |
| 176 | Plasma Proprotein Convertase Subtilisin/Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism? | 1.1 | 63 | Citations (PDF) |
| 177 | HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity | 5.4 | 152 | Citations (PDF) |
| 178 | Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome | 9.6 | 16 | Citations (PDF) |
| 179 | Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes | 1.2 | 193 | Citations (PDF) |
| 180 | Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts | 2.9 | 29 | Citations (PDF) |
| 181 | Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats | 0.9 | 27 | Citations (PDF) |
| 182 | Molecular basis of PCSK9 function | 0.9 | 175 | Citations (PDF) |
| 183 | Cholesterol metabolism and pancreatic β-cell function | 4.0 | 81 | Citations (PDF) |
| 184 | ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein <i>in vitro</i> | 4.0 | 129 | Citations (PDF) |
| 185 | Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats | 1.2 | 39 | Citations (PDF) |
| 186 | POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease | 0.9 | 18 | Citations (PDF) |
| 187 | Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo | 0.9 | 83 | Citations (PDF) |
| 188 | Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa | 0.9 | 85 | Citations (PDF) |
| 189 | Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes | 7.5 | 192 | Citations (PDF) |
| 190 | Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein | 3.6 | 20 | Citations (PDF) |
| 191 | Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice | 3.6 | 27 | Citations (PDF) |
| 192 | Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment | 1.1 | 155 | Citations (PDF) |
| 193 | Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | 5.4 | 198 | Citations (PDF) |
| 194 | Antiinflammatory Actions of HDL | 5.4 | 66 | Citations (PDF) |
| 195 | Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice | 3.6 | 56 | Citations (PDF) |
| 196 | Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome | 9.6 | 98 | Citations (PDF) |
| 197 | Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation | 2.3 | 179 | Citations (PDF) |
| 198 | Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis | 3.6 | 13 | Citations (PDF) |
| 199 | Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis | 5.4 | 117 | Citations (PDF) |
| 200 | N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins | 3.6 | 24 | Citations (PDF) |
| 201 | Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation | 0.9 | 37 | Citations (PDF) |
| 202 | Differences in plasma PLTP activity assays: constant or random error? | 2.5 | 1 | Citations (PDF) |
| 203 | Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration | 5.2 | 70 | Citations (PDF) |
| 204 | New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease | 3.1 | 99 | Citations (PDF) |
| 205 | ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis | 0.9 | 16 | Citations (PDF) |
| 206 | Consumption of Saturated Fat Impairs the Anti-Inflammatory Properties of High-Density Lipoproteins and Endothelial Function | 1.2 | 191 | Citations (PDF) |
| 207 | What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport? | 5.4 | 150 | Citations (PDF) |
| 208 | Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis | 1.2 | 6 | Citations (PDF) |
| 209 | Relationship between the concentration and antiatherogenic activity of high-density lipoproteins | 4.0 | 41 | Citations (PDF) |
| 210 | Plasma phospholipid transfer protein activity, a determinant of HDL kineticsin vivo | 2.5 | 6 | Citations (PDF) |
| 211 | Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit | 3.6 | 17 | Citations (PDF) |
| 212 | Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells | 3.5 | 35 | Citations (PDF) |
| 213 | Are we lowering LDL cholesterol sufficiently? | 3.8 | 7 | Citations (PDF) |
| 214 | High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice | 5.4 | 175 | Citations (PDF) |
| 215 | The Argument Against the Appropriateness of Over-the-Counter Statins | 10.1 | 9 | Citations (PDF) |
| 216 | Cardioprotective Properties of Fibrates | 10.1 | 57 | Citations (PDF) |
| 217 | Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E | 3.6 | 32 | Citations (PDF) |
| 218 | ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I | 5.4 | 392 | Citations (PDF) |
| 219 | High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics | 4.5 | 54 | Citations (PDF) |
| 220 | Homocysteine and Cardiovascular Disease | 11.3 | 32 | Citations (PDF) |
| 221 | High-density lipoproteins as therapeutic targets | 4.0 | 38 | Citations (PDF) |
| 222 | Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity | 6.7 | 85 | Citations (PDF) |
| 223 | Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits | 10.1 | 280 | Citations (PDF) |
| 224 | Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits | 5.4 | 149 | Citations (PDF) |
| 225 | Apolipoprotein E activates the low-activity form of human phospholipid transfer protein | 2.1 | 35 | Citations (PDF) |
| 226 | Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I | 5.4 | 285 | Citations (PDF) |
| 227 | Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation | 2.3 | 129 | Citations (PDF) |
| 228 | High-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity | 10.1 | 151 | Citations (PDF) |
| 229 | Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux | 2.3 | 43 | Citations (PDF) |
| 230 | Antiinflammatory Properties of HDL | 11.3 | 1,283 | Citations (PDF) |
| 231 | Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation | 2.3 | 51 | Citations (PDF) |
| 232 | Metabolism of ApoA-I as Lipid-Free Protein or as Component of Discoidal and Spherical Reconstituted HDLs | 5.4 | 43 | Citations (PDF) |
| 233 | Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells | 4.0 | 128 | Citations (PDF) |
| 234 | Evidence that Phospholipids Play a Key Role in Pre-β ApoA-I Formation and High-Density Lipoprotein Remodeling† | 2.9 | 32 | Citations (PDF) |
| 235 | Cholesteryl ester transfer protein, high density lipoprotein and arterial disease | 4.0 | 44 | Citations (PDF) |
| 236 | The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein | 2.3 | 114 | Citations (PDF) |
| 237 | Formation of Spherical, Reconstituted High Density Lipoproteins Containing Both Apolipoproteins A-I and A-II Is Mediated by Lecithin:Cholesterol Acyltransferase | 2.3 | 57 | Citations (PDF) |
| 238 | Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I | 2.3 | 67 | Citations (PDF) |
| 239 | High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway | 2.3 | 216 | Citations (PDF) |
| 240 | Remodelling of high density lipoproteins by plasma factors | 0.9 | 246 | Citations (PDF) |
| 241 | Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells | 3.6 | 135 | Citations (PDF) |
| 242 | Factors Influencing the Ability of HDL to Inhibit Expression of Vascular Cell Adhesion Molecule-1 in Endothelial Cells | 5.4 | 184 | Citations (PDF) |
| 243 | The Influence of Apolipoproteins on the Hepatic Lipase-mediated Hydrolysis of High Density Lipoprotein Phospholipid and Triacylglycerol | 2.3 | 37 | Citations (PDF) |
| 244 | Oxidation of High Density Lipoproteins | 2.3 | 303 | Citations (PDF) |
| 245 | Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein | 3.6 | 84 | Citations (PDF) |
| 246 | Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion | 2.3 | 92 | Citations (PDF) |
| 247 | Molecular mechanisms of reverse cholesterol transport | 4.0 | 166 | Citations (PDF) |
| 248 | The Influence of Sphingomyelin on the Structure and Function of Reconstituted High Density Lipoproteins | 2.3 | 83 | Citations (PDF) |
| 249 | High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules | 5.4 | 721 | Citations (PDF) |
| 250 | The Influence of Cholesteryl Ester Transfer Protein on the Composition, Size, and Structure of Spherical, Reconstituted High Density Lipoproteins | 2.3 | 67 | Citations (PDF) |
| 251 | Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools | 2.4 | 70 | Citations (PDF) |
| 252 | CHOLESTERYL ESTER TRANSFER PROTEIN: ITS ROLE IN PLASMA LIPID TRANSPORT | 2.3 | 41 | Citations (PDF) |
| 253 | Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II | 2.4 | 41 | Citations (PDF) |
| 254 | Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins | 2.4 | 31 | Citations (PDF) |
